Cellebrite DI (CLBT) Shares Climbed, What Is Driving Attention Now?

Why Cellebrite DI’s Upcoming Earnings and SkySafe Partnership Matter Now

Cellebrite DI (NasdaqGS:CLBT) heads into its second quarter 2026 earnings report on 13 August, shortly after expanding its exclusive SkySafe partnership focused on drone detection and airspace intelligence for digital investigations.

This combination of an imminent earnings update and a broader technology partnership has drawn fresh attention to Cellebrite DI among investors who follow digital forensics and public sector software stocks.

See our latest analysis for Cellebrite DI.

The share price of Cellebrite DI, which last closed at US$16.01, has seen a 25.67% 90 day share price return, while the year to date share price return is down 10.26% and the 3 year total shareholder return stands at 108.46%. This points to long term momentum alongside some recent hesitation.

If Cellebrite DI’s mix of digital forensics and drone related tools has caught your attention, you may also want to see which other companies are gaining traction in applied AI using the 71 profitable AI stocks that aren't just burning cash.

After a strong 3 year run and a softer year to date, plus fresh attention on the SkySafe tie up, some investors will feel pressure to act quickly on Cellebrite DI. Others may prefer to wait for a cleaner entry as valuation comes into focus next.

Most Popular Narrative: 23.8% Undervalued

The most followed narrative currently places Cellebrite DI’s fair value at $21.00 compared with the recent $16.01 close, which sets up a clear valuation gap for investors to assess.

The continued transition to a recurring, subscription-based revenue model with over 90% of revenues now from subscriptions and growing SaaS/cloud penetration improves revenue visibility, predictability, and operating leverage, which is already translating into higher EBITDA and free cash flow margins and is likely underappreciated in current valuations.

Read the complete narrative.

Want to see what sits behind that confidence in Cellebrite DI’s subscription engine? The narrative focuses on this model and notes that it is associated with expectations around future growth, margin expansion and a rich earnings multiple that is usually reserved for sector leaders.

Result: Fair Value of $21.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this Cellebrite DI narrative still depends on US federal demand normalising, as well as on the company keeping pace with tightening privacy rules and faster mobile security advances.

Find out about the key risks to this Cellebrite DI narrative.

Another View on Cellebrite DI’s Valuation

The narrative and analyst target suggest Cellebrite DI is undervalued, yet the current 56x P/E is well above the US Software industry at 32.5x and above a fair ratio of 32x, even though it sits just below peer average at 57.7x. That points to meaningful valuation risk if sentiment cools. How comfortable are you paying this kind of premium for the growth story?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mix of optimism and caution around Cellebrite DI, now is a good time to review the full picture yourself. To see how the current upside case compares with potential downsides, take a closer look at the 3 key rewards and 1 important warning sign.

Looking For More Investment Ideas Beyond Cellebrite DI?

If you like the story around Cellebrite DI, do not stop here. The next set of stock ideas could be where your best opportunities sit.

• Target dependable cash generators by reviewing companies on the 52 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect them.
• Strengthen the defensive side of your portfolio by scanning the solid balance sheet and fundamentals stocks screener (48 results) for businesses with robust financial footing.
• Get ahead of the crowd by checking the screener containing 21 high quality undiscovered gems before these quieter opportunities attract broader attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com